Voyager Lifts Off With $45M From Third Rock Ventures. By Paul Bonanos, The pink Sheet, February 12 2014
Voyager hopes to have three programs in the clinic by early 2017, targeting Parkinson’s, ALS and Friedreich’s ataxia.
Friedreich Ataxia and close related scientific news. Topics related to rare diseases.